Back to top

Check-Cap ‘publicly condemned’ MediPharm Labs, Chairman Chris Taves

The company said, “Check-Cap (CHEK) publicly condemned MediPharm Labs (MEDIF) (MEDF)) and its Chairman, Chris Taves, Head of Asia for BMO Capital M...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Check-Cap Ltd. (CHEK)